News
Work on the collaboration will be carried out at the recently opened Wacker Biotechnology Center at the company’s central R&D site in Munich.
WACKER and Gearbox Biosciences have launched a partnership to co-develop advanced, antibiotic-free pDNA manufacturing techniques aimed at improvi ...
STONY BROOK, NY / ACCESS Newswire / July 24, 2025 / Applied DNA Sciences, Inc. (NASDAQ:APDN) (“Applied DNA” or the “Company”), a leader in synthetic DNA manufacturing powered by scalable PCR platforms ...
Imunon has confirmed the deprioritization of its COVID-19 vaccine program. With the company’s cash reserves falling below $5 ...
Detailed price information for Charles River Laboratories Intl (CRL-N) from The Globe and Mail including charting and trades.
15d
News-Medical.Net on MSNNovel DNA plasmid therapy shows high success rate in treating chronic pain in dogsElenagen™, a novel DNA plasmid therapy that previously demonstrated high clinical benefit and low toxicity in cancer patients, has now shown significant promise in alleviating chronic pain ...
8d
News-Medical.Net on MSNInnovative nanopore system enables controlled DNA unzippingDNA holds the instructions that make us who we are. If we want to read those instructions, say to understand our ...
DNA holds the instructions that make us who we are. If we want to read those instructions, say, to understand our ...
Addgene, a purpose-driven organization helping scientists conduct experiments with greater ease, speed, and reproducibility, ...
The report offers an in-depth analysis of vectorized antibodies via in vivo expression of DNA/RNA. It explores stakeholders, R&D pipelines, drug compositions, and business deals as of June 2025, ...
Study in Frontiers in Veterinary Science finds investigational plasmid Elenagen cut osteoarthritis pain by 50 % in dogs and restored mobility, pointing to a potential non‑opioid approach for ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results